OpenEye Scientific is now part of Cadence
LEAD OPTIMIZATION

SCOPE: Shape and Color-based Prediction Ensemble

OpenEye’s 3D-QSAR with built-in prediction confidence

SCOPE is OpenEye’s 3D Quantitative Structure–Activity Relationship (3D-QSAR) solution for predicting binding affinity. It uses molecular similarity between aligned ligands as the primary descriptor, combining multiple models with different similarity descriptors and machine learning techniques. The model's prediction is a consensus of individual model predictions.

Contact us to see how SCOPE can sharpen your lead optimization decisions.

3D QSAR shape and features image
SCOPE generates easily interpretable maps of where in the model chemical features such as hydrogen bond donors and acceptors contribute positively to binding affinity.

Features

  • Cutting Edge. Descriptors based on our industry leading OpenEye 3D shape and electrostatic tools (ROCS and EON).

  • Robust. Prediction provided as consensus of multiple models.

  • Flexible. Uses your 3D conformers or generates them with OpenEye tools.

  • Confidence. Prediction confidence based on domain of applicability. 

  • Interpretable. Model interpretation indicating favorable sites of functional groups.

Inspiring new ideas through the interpretation of visual models

A common challenge for 3D-QSAR is interpretation. SCOPE keeps the model readable, helping scientists interpret regions within the active site, indicating preferences for specific features.

SCOPE doesn’t assume anything about the receptor/binding site. It picks out the features that contribute most to the model. These interpretations can inspire new ideas and make the model a useful part of a generative design cycle.

3D QSAR interpretable models
Model interpretation indicating preference sites of molecules
FE-NES and SCOPE combination active learning
Active learning with SCOPE and FE-NES provides medicinal chemists with rank-ordered hit lists and key structural insights into potency drivers, supporting confident SAR-driven design decisions.

Scale Lead Optimization with SCOPE and Binding Free Energy Predictions

Building models from measured affinities is effective but limited by the time and cost required to perform the experiments. SCOPE can be used in active learning workflows to build models based on predicted affinity data from our relative binding free energy tool, FE-NES.

In a retrospective study of a library of over 4500 Tyk2 ligands, ten rounds of active learning with 50 FE-NES predictions each (therefore requiring only 500 FE-NES calculations in total) identified 56 molecules with higher predicted potency than any identified experimentally, providing potential new starting points for a new round of lead optimization.

Read the Science Brief

Innovative science designed in collaboration with industry partners

We developed SCOPE in partnership with multiple drug discovery companies. Leveraging OpenEye’s cutting-edge expertise in 3D shape and electrostatics, this 3D-QSAR approach provides drug discovery scientists with results that are interpretable and actionable for use in drug discovery.

3D QSAR floe package graphic
OpenEye's SCOPE workflow combines shape similarity descriptors with machine learning models.

Learn More

SCOPE: From Shape and Color to Binding Affinity, with Confidence. Chen et al. [Preprint] Research Square.  September 2026. 

3D QSAR Model for Binding Affinity Prediction. Shyamal K. Nath, Jingyi Chen, Ali Mozaffari and Riddhish Pandharkar. Ninth Joint Sheffield Conference on Chemoinformatics, University of Sheffield, UK, June 2023.

New 3D-QSAR Model for Binding Affinity Prediction. Ali Mozaffari, Jingyi Chen, Shyamal K. Nath. ACS Fall Meeting, San Francisco, CA, August 2023.

References

  1. Comparison of Shape-Matching and Docking as Virtual Screening Tools. Hawkins, P.C.D., Skillman, A.G., Nicholls, A., J. Med. Chem., 2007, 50, 74.
  2. The Use of Three-Dimensional Shape and Electrostatic Similarity Searching in the Identification of a Melanin-Concentrating Hormone Receptor 1 Antagonist S. Muchmore, A. J. Souers, I. Akritopoulou-Zanze, Chem. Biol. Drug Des., 2006, 67, 174.

Webinar: From Prediction to Decision: Streamlining Binding Affinity Workflows
Webinar: Getting More From Your Cryo-EM Data
Webinar: Is the era of "I can't code" over? A chemists' guide to coding with agents.
Webinar: Target X: An Unobstructed View of Pockets
Webinar: Improving the Core: Not Resting on Our Laurels
Webinar: Too Hot, Too Cold, or Past Midnight? Statistical Considerations in Lead Optimization from Goldilocks & Cinderella
Webinar: AI For Drug Discovery
cta-bg-desktop cta-bg-mobile
Get Started

Accelerate your Science with OpenEye